Articles Tagged With:
-
Dexmedetomidine for Sedation in Patients Undergoing Mechanical Ventilation in the ICU
This special feature will focus on dexmedetomidine as a sedative for invasive mechanical ventilation in the ICU.
-
Contemplating the Next Pandemic
We have heard much about the inevitable “next pandemic” as viruses move and mutate through animals until they become infectious in humans. An example of this was published recently, revealing how an avian flu virus caused fatal infections in swans, seals, and a fox, a “terrestrial mammal” not usually vulnerable to such a virus.
-
The Return of Flu: Signs Point to Possible Severe Season
A possible severe influenza season is on the horizon, in part because COVID-19 shutdowns and precautions led to a historically low flu season in 2019-2020, said Rochelle Walensky, MD, director of the Centers for Disease Control and Prevention.
-
Booster Option for HCWs Approved as CDC Overrules Advisory Panel
Centers for Disease Control and Prevention Director Rochelle Walensky, MD, MPH, is defending her decision to overrule her own vaccine advisory committee after they voted against giving COVID-19 booster shots to healthcare workers, teachers, and other essential workers at occupational risk of infections.
-
Delta Variant Spreads Exponentially in United States with Millions Unvaccinated
The delta variant of COVID-19 has spread exponentially in the United States, with 96% of counties reporting high (90%) or substantial (6%) transmission as of Oct. 8, 2021.
-
Use of Ursodeoxycholic Acid in Pregnant Women with Obstetric Cholestasis
Ursodeoxycholic acid might be beneficial in reducing the risk of spontaneous preterm birth and meconium-stained amniotic fluid, but not stillbirths, in women with pregnancies complicated by obstetric cholestasis.
-
Menopausal Hot Flashes: Can a Plant-Based Diet Provide Effective Treatment?
In this clinical trial, women randomized to a low-fat, vegan diet including one-half cup of cooked whole soybeans daily experienced a reduction in total hot flashes of 79% compared to 49% in the control group over 12 weeks of observation.
-
Do Women 64 to 66 Years of Age Qualify to Discontinue Cervical Screening?
These studies evaluated adherence to national guidelines for exiting from cervical cancer screening at 65 years of age and managing abnormal results on screening with human papillomavirus (HPV) and Pap co-testing and found that the majority of women 64 to 66 years of age do not qualify to discontinue screening, and the majority of women with discordant Pap and HPV test results are managed incorrectly.
-
Pediatric Mental Health in the Emergency Department
The increasing volume of children with mental health conditions across all acute care settings highlights the need for ED providers to be familiar with the most common mental health presentations in the pediatric population to effectively engage with and provide proper care for and disposition to this at-risk population. -
SARS-CoV-2 Infection During Pregnancy and Increased Risk of Preeclampsia
A meta-analysis of 28 observational studies found that having SARS-CoV-2 infection during pregnancy was associated with a 58% increase in the adjusted odds of having preeclampsia compared to those without SARS-CoV-2 infection during pregnancy.